Growth Equity Opportunities V, Llc - Net Worth and Insider Trading
Growth Equity Opportunities V, Llc Net Worth
The estimated net worth of Growth Equity Opportunities V, Llc is at least $948,306 dollars as of 2024-11-10. Growth Equity Opportunities V, Llc is the 10% Owner of Regulus Therapeutics Inc and owns about 645,106 shares of Regulus Therapeutics Inc (RGLS) stock worth over $948,306. Details can be seen in Growth Equity Opportunities V, Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Growth Equity Opportunities V, Llc has not made any transactions after 2020-12-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Growth Equity Opportunities V, Llc
Growth Equity Opportunities V, Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Growth Equity Opportunities V, Llc owns 1 companies in total, including Regulus Therapeutics Inc (RGLS) .
Insider Ownership Summary of Growth Equity Opportunities V, Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RGLS | Regulus Therapeutics Inc | 2020-12-04 | 10 percent owner |
Growth Equity Opportunities V, Llc Latest Holdings Summary
Growth Equity Opportunities V, Llc currently owns a total of 1 stock. Growth Equity Opportunities V, Llc owns 645,106 shares of Regulus Therapeutics Inc (RGLS) as of December 4, 2020, with a value of $948,306.
Latest Holdings of Growth Equity Opportunities V, Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RGLS | Regulus Therapeutics Inc | 2020-12-04 | 645,106 | 1.47 | 948,306 |
Holding Weightings of Growth Equity Opportunities V, Llc
Growth Equity Opportunities V, Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Growth Equity Opportunities V, Llc has made a total of 1 transactions in Regulus Therapeutics Inc (RGLS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Regulus Therapeutics Inc is the acquisition of 439,860 shares on December 4, 2020, which cost Growth Equity Opportunities V, Llc around $3 Million.
Insider Trading History of Growth Equity Opportunities V, Llc
- 1
Growth Equity Opportunities V, Llc Trading Performance
GuruFocus tracks the stock performance after each of Growth Equity Opportunities V, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Growth Equity Opportunities V, Llc is 1.41%. GuruFocus also compares Growth Equity Opportunities V, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Growth Equity Opportunities V, Llc within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Growth Equity Opportunities V, Llc's insider trading performs compared to the benchmark.
Performance of Growth Equity Opportunities V, Llc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 23.35 | | | | | |
| Relative Return to S&P 500(%) | 23.51 | | | | | |
Growth Equity Opportunities V, Llc Ownership Network
Ownership Network List of Growth Equity Opportunities V, Llc
Ownership Network Relation of Growth Equity Opportunities V, Llc
Growth Equity Opportunities V, Llc Owned Company Details
What does Regulus Therapeutics Inc do?
Who are the key executives at Regulus Therapeutics Inc?
Growth Equity Opportunities V, Llc is the 10 percent owner of Regulus Therapeutics Inc. Other key executives at Regulus Therapeutics Inc include Chief Financial Officer Crispina Calsada , Sr. VP & General Counsel Christopher Ray Aker , and Chief Operating Officer Joseph P Hagan .
Regulus Therapeutics Inc (RGLS) Insider Trades Summary
Over the past 18 months, Growth Equity Opportunities V, Llc made no insider transaction in Regulus Therapeutics Inc (RGLS). Other recent insider transactions involving Regulus Therapeutics Inc (RGLS) include a net sale of 14,580 shares made by Joseph P Hagan , a net sale of 5,468 shares made by Crispina Calsada , and a net sale of 5,468 shares made by Christopher Ray Aker .
In summary, during the past 3 months, insiders sold 0 shares of Regulus Therapeutics Inc (RGLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 25,516 shares of Regulus Therapeutics Inc (RGLS) were sold and 4,000 shares were bought by its insiders, resulting in a net sale of 21,516 shares.
Regulus Therapeutics Inc (RGLS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Regulus Therapeutics Inc Insider Transactions
Growth Equity Opportunities V, Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Growth Equity Opportunities V, Llc. You might contact Growth Equity Opportunities V, Llc via mailing address: 1954 Greenspring Drive, Suite 600, Timonium Md 21093.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
